Ra Medical Systems Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares Oct 1, 2018
Ra Medical Systems Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering May 29, 2018
Ra Medical Systems Granted Broad Patent for DABRA Catheter for Cardiovascular Disease Treatment Jul 17, 2017
Ra Medical Systems Names Maurice Buchbinder, M.D., and Martin Colombatto to Board of Directors Jul 11, 2017
Heart Endovascular & Rhythm of Texas Begins First Commercial, FDA-Cleared, In-Patient Use of DABRA™ to Treat Peripheral Artery Disease Jun 26, 2017
